Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.
Frequently asked questions
What sector does Carasent ASA (CARA) operate in?
Carasent ASA belongs to the Other sector and operates in the Health Information Services industry.
What is Carasent ASA (CARA) current stock price?
As of the latest data, Carasent ASA stock price is SEK 26.35, with a previous close of SEK 26.30. Carasent ASA gained SEK 0.05 in the last trading session, representing a 0.19% increase.
What is Carasent ASA (CARA) current market capitalization?
Carasent ASA market cap is approximately 1.76 billion.
What is Carasent ASA (CARA) Earnings Per Share (EPS)?
The trailing EPS is SEK 0.62, and the forward EPS is SEK 1.01.
What is Carasent ASA (CARA) Price-to-Earnings (P/E) ratio?
Carasent ASA current P/E ratio is 42.5, with a forward P/E of 26.09.
What is Carasent ASA (CARA) EBITDA?
Carasent ASA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 14.78 million.
Does Carasent ASA (CARA) pay dividends?
No. Carasent ASA does not pay a dividend.
How did Carasent ASA (CARA) perform in its most recent earnings report?
In the last report (June 30, 2026), Carasent ASA posted an EPS surprise of -500% and a revenue surprise of 2.76%.
What is Carasent ASA (CARA) beta (volatility) score?
Carasent ASA has a beta of 0.269, indicating lower volatility than the overall market.
